Profit From Walgreen-CVS Dispute
WALGREEN CO. ANNOUNCED on Monday that it would no longer participate in CVS Caremark's prescription benefit network plan, setting off a dispute that has hurt both stocks.
Each company stands to lose business if customers in CVS Caremark's (ticker: CVS) prescription benefit network can no longer get drugs from Walgreen (ticker: WAG).
Still, we think CVS Caremark has more to lose in this dust-up.
According to Morningstar, only about 15% of CVS Caremark's pharmacy network customers fill prescriptions at CVS drugstores, leaving the company reliant on other ...
source:Barron's
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment